NCT06244446View on ClinicalTrials.gov

Efficacy and Safety of SBRT Combined With Atezolizumab Plus Bevacizumab vs Atezolizumab Plus Bevacizumab in Treating Unresectable Advance Hepatocellular Carcinoma.

Not yet recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

February 5, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Advanced Hepatocellular Carcinoma
Interventions
OTHER

No intervention

No intervention. It is an observational study

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences, New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT06244446 - Efficacy and Safety of SBRT Combined With Atezolizumab Plus Bevacizumab vs Atezolizumab Plus Bevacizumab in Treating Unresectable Advance Hepatocellular Carcinoma. | Biotech Hunter | Biotech Hunter